TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/04/2026
Voltar para busca
Dado oficial do USPTO
IOVANCE BIOTHERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
IOVANCE BIOTHERAPEUTICS
ST13
US500000090398613Classe
38, 42
Pedido
90398613
Registro
7922016
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
57
Atualização mais recente
09/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
38, 42
Data de depósito
21/12/2020
Data de registro
26/08/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/08/2025
Última transação
09/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
16/02/2024
Primeiro uso no comércio
16/02/2024
Código do desenho
4
Tipo de titular
03
Localização do titular
San Carlos, CA, US
Examinador
LEE, YATSYE ISADORA
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Iovance Biotherapeutics, Inc.
Representantes
Carla B. Oakley MORGAN, LEWIS & BOCKIUS LLP
Classificação técnica
Classes Nice
Classe 38Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 38
telecommunications servicestransmission of data and graphics between healthcare providers via global and local computer networks in the fields of telehealth and telemedicine
Classe 42
providing temporary use of non-downloadable computer software for scheduling and tracking medical patient appointmentsmedical laboratory servicesmedical proceduresfor use in providing data analytics in the fields of medical researchcancer treatments and drug and immunotherapy development; software as a service (SaaS) services featuring software for tracking and monitoring chain of custody and chain of identity of cell therapies; providing medical and scientific research information in the field of drug development and medical treatment development for delivering streamlined treatment information and improving communication among stakeholders in providing medical treatment; providing medical and scientific research information in the fields of medical research and cancer treatments; software as a service (SAAS) services featuring software for collectingorganizingobtainingmanaging patient informationfacilitating and handling communications between patients and providersproviding advice and referrals in the fields of medicinemedical carehealthcare; platform as a service (PAAS) featuring computer software platforms for online collectingorganizingobtainingmanaging patient informationfacilitating and handling communications between patients and providers; software as a service (SAAS) services featuring software for managing the supply of tumor shipperstemperature monitors and GPS trackers provided to sites involved in the provision of immunotherapy treatments and cancer treatments
Publicações
Histórico de despachos e eventos da marca no USPTO.
57 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/04/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/04/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
26/08/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
26/08/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/08/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/08/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/06/2025
ALIE
ASSIGNED TO LIE
16/06/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/06/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
10/03/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
10/03/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/12/2024
GNRT
NON-FINAL ACTION E-MAILED
10/12/2024
CNRT
SU - NON-FINAL ACTION - WRITTEN
10/12/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
19/11/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
19/11/2024
IUAF
USE AMENDMENT FILED
16/09/2024
EISU
TEAS STATEMENT OF USE RECEIVED
16/09/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
14/03/2024
EX5G
SOU EXTENSION 5 GRANTED
13/03/2024
EXT5
SOU EXTENSION 5 FILED
13/03/2024
EEXT
SOU TEAS EXTENSION RECEIVED
13/03/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16/08/2023
EX4G
SOU EXTENSION 4 GRANTED
14/08/2023
EXT4
SOU EXTENSION 4 FILED
14/08/2023
EEXT
SOU TEAS EXTENSION RECEIVED
14/08/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
21/02/2023
EX3G
SOU EXTENSION 3 GRANTED
17/02/2023
EXT3
SOU EXTENSION 3 FILED
17/02/2023
EEXT
SOU TEAS EXTENSION RECEIVED
17/02/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/09/2022
EX2G
SOU EXTENSION 2 GRANTED
01/09/2022
EXT2
SOU EXTENSION 2 FILED
01/09/2022
EEXT
SOU TEAS EXTENSION RECEIVED
01/09/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
23/02/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
23/02/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
23/02/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
23/02/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
23/02/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29/01/2022
EX1G
SOU EXTENSION 1 GRANTED
27/01/2022
EXT1
SOU EXTENSION 1 FILED
27/01/2022
EEXT
SOU TEAS EXTENSION RECEIVED
27/01/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
14/09/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/07/2021
PUBO
PUBLISHED FOR OPPOSITION
20/07/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
30/06/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/06/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
16/06/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
16/06/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
16/06/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
16/06/2021
DOCK
ASSIGNED TO EXAMINER
16/06/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/03/2021
NWAP
NEW APPLICATION ENTERED
24/12/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace IOVANCE BIOTHERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.